A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomesSCIENTIFIC REPORTSIF3.92023-12-152OAAI
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorderclinical psychology science and practiceIF3.22021-11-276OAAI
The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal BehaviorFRONTIERS IN PSYCHIATRYIF3.22021-09-109OAAI
Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?HARM REDUCTION JOURNALIF42021-07-0816OAAI
The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trialsBRAZILIAN JOURNAL OF PSYCHIATRYIF2.62021-04-0116OAAI
GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocolSYSTEMATIC REVIEWSIF3.92020-09-011OAAI
Genetic determinants of cannabis use: a systematic review protocolSYSTEMATIC REVIEWSIF3.92020-08-203OAAI
The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort studyDRUG AND ALCOHOL DEPENDENCEIF3.62020-04-016PREAI
The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatmentBJPSYCH OPENIF3.52019-10-189OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向